Monday, January 20, 2025
spot_img

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

COPENHAGEN, Denmark, January 20, 2025 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on January 9, 2025, under which the Company will repurchase shares for an amount up to DKK 150 million in the period from January 9, 2025 to February 5, 2025. The program is executed in accordance with Regulation (EU) No. 596/2014 (as amended) of the European Parliament and of the Council on market abuse and Commission Delegated Regulation (EU) 2016/1052, which together constitute the Safe Harbour Regulation.

Since initiation of the program, the following transactions have been made:

  Number of shares Average purchase price, DKK Transaction value, DKK
January 9, 2025 47,000 205.20 9,644,400
January 10, 2025 50,000 204.07 10,203,500
January 13, 2025 53,000 196.50 10,414,500
January 14, 2025 55,000 196.37 10,800,350
January 15, 2025 53,000 191.71 10,160,630
January 16, 2025 50,000 195.53 9,776,500
January 17, 2025 50,000 196.13 9,806,500
Accumulated under the program 358,000 197.78 70,806,380

The details for each transaction made under the share repurchase program are published on bavarian-nordic.com.

Following these transactions, Bavarian Nordic holds a total of 642,235 treasury shares, corresponding to 0.81 % of the Company’s share capital.

About Bavarian Nordic
Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit www.bavarian-nordic.com.

Forward-looking statements
This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law.

Contact investors:
Europe: Rolf Sass Sørensen, Vice President Investor Relations, [email protected], Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, [email protected], Tel: +1 781 686 9600

Contact media:
Nicole Seroff, Vice President Corporate Communications, [email protected], Tel: + 45 53 88 06 03

Company Announcement no. 02 / 2025

Attachments

  • 2025-02-en
  • 2025-02-appendix-en

Powered by SlickText.com

Hot this week

Atos publishes estimated 2024 year-end liquidity position well above business plan

Press Release Atos publishes estimated 2024 year-end liquidity...

Banijay Group: weekly share transactions

Press Release Paris – 20 January 2025 ...

Redemption of green convertible bonds (OCEANEs vertes)

Redemption of green convertible bonds (OCEANEs vertes) Voltalia...

Acquisition of own shares

Acquisition of own shares Brussels, Belgium – January...

Topics

Atos publishes estimated 2024 year-end liquidity position well above business plan

Press Release Atos publishes estimated 2024 year-end liquidity...

Banijay Group: weekly share transactions

Press Release Paris – 20 January 2025 ...

Redemption of green convertible bonds (OCEANEs vertes)

Redemption of green convertible bonds (OCEANEs vertes) Voltalia...

Acquisition of own shares

Acquisition of own shares Brussels, Belgium – January...

Ageas reports on the progress of share buy-back programme

Further to the initiation of the share buy-back programme...

ProVen VCT plc: Director/PDMR Shareholding

ProVen VCT plc Director/PDMR Shareholding 17 January 2025ProVen VCT...
spot_img

Related Articles

Popular Categories

spot_img